$70M Awarded In Risperdal Gynecomastia Trial In Pennsylvania State Court
PHILADELPHIA — A Pennsylvania state court jury on July 1 awarded $70 million to a man who says Janssen Pharmaceuticals Inc. failed to warn that its Risperdal atypical antipsychotic drug can...To view the full article, register now.
Already a subscriber? Click here to view full article